Literature DB >> 7752194

Buspirone analogues as ligands of the 5-HT1A receptor. 1. The molecular structure of buspirone and its two analogues.

Z Chilmonczyk1, A Leś, A Woźniakowska, J Cybulski, A E Kozioł, M Gdaniec.   

Abstract

An interdisciplinary (X-ray, 1H and 13C NMR, IR, and theoretical quantum mechanical) study on the potent 5-HT1A receptor ligand buspirone (1) and its two structural analogues, mesmar (4,4-dimethyl-1-[4-[4-(2-quinolinyl)-1-piperazinyl]butyl]-2,6- piperidinedione) (2) and kaspar (8-[4-[4-(2-quinolinyl)-1-piperazinyl]butyl]-8-azaspiro[4.5]decane - 7,9-dione) (3), has been reported. The results have shown that buspirone-like molecules should appear in an extended rod-shape form, possessing several potential interaction sites with the receptor.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7752194     DOI: 10.1021/jm00010a015

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  4 in total

1.  Synthesis, in vitro binding studies and docking of long-chain arylpiperazine nitroquipazine analogues, as potential serotonin transporter inhibitors.

Authors:  Małgorzata Jarończyk; Karol Wołosewicz; Mari Gabrielsen; Gabriel Nowak; Irina Kufareva; Aleksander P Mazurek; Aina W Ravna; Ruben Abagyan; Andrzej J Bojarski; Ingebrigt Sylte; Zdzisław Chilmonczyk
Journal:  Eur J Med Chem       Date:  2012-01-15       Impact factor: 6.514

2.  Molecular dynamics of 5-HT1A and 5-HT2A serotonin receptors with methylated buspirone analogues.

Authors:  A Bronowska; Z Chilmonczyk; A Leś; O Edvardsen; R Ostensen; I Sylte
Journal:  J Comput Aided Mol Des       Date:  2001-11       Impact factor: 3.686

3.  Classification of 5-HT(1A) receptor ligands on the basis of their binding affinities by using PSO-Adaboost-SVM.

Authors:  Zhengjun Cheng; Yuntao Zhang; Changhong Zhou; Wenjun Zhang; Shibo Gao
Journal:  Int J Mol Sci       Date:  2009-07-29       Impact factor: 6.208

4.  Design, Synthesis, and Biological Evaluation of a Series of 5- and 7-Hydroxycoumarin Derivatives as 5-HT1A Serotonin Receptor Antagonists.

Authors:  Kinga Ostrowska; Anna Leśniak; Zuzanna Czarnocka; Jagoda Chmiel; Magdalena Bujalska-Zadrożny; Bartosz Trzaskowski
Journal:  Pharmaceuticals (Basel)       Date:  2021-02-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.